These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25354259)

  • 1. Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA.
    Varela I; Karagiannidou A; Oikonomakis V; Tzetis M; Tzanoudaki M; Siapati EK; Vassilopoulos G; Graphakos S; Kanavakis E; Goussetis E
    Cell Reprogram; 2014 Dec; 16(6):447-55. PubMed ID: 25354259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity.
    Kang R; Zhou Y; Tan S; Zhou G; Aagaard L; Xie L; Bünger C; Bolund L; Luo Y
    Stem Cell Res Ther; 2015 Aug; 6(1):144. PubMed ID: 26282538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of bone marrow derived mesenchymal stromal cells to human induced pluripotent stem cells from pediatric patients with hematological diseases using a commercial mRNA kit.
    Sfougataki I; Grafakos I; Varela I; Mitrakos A; Karagiannidou A; Tzannoudaki M; Poulou M; Mertzanian A; Roubelakis G M; Stefanaki K; Traeger-Synodinos J; Kanavakis E; Kitra V; Tzetis M; Goussetis E
    Blood Cells Mol Dis; 2019 May; 76():32-39. PubMed ID: 30709626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
    Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
    Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
    Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
    Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of pluripotency in human umbilical cord mesenchymal stem cells in feeder layer-free condition.
    Daneshvar N; Rasedee A; Shamsabadi FT; Moeini H; Mehrboud P; Rahman HS; Boroojerdi MH; Vellasamy S
    Tissue Cell; 2015 Dec; 47(6):575-82. PubMed ID: 26471847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors.
    Layh-Schmitt G; Lu S; Navid F; Brooks SR; Lazowick E; Davis KM; Montagna C; Gadina M; Colbert RA
    Clin Rheumatol; 2017 Jan; 36(1):143-154. PubMed ID: 27864696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human menstrual blood-derived mesenchymal cells as a cell source of rapid and efficient nuclear reprogramming.
    de Carvalho Rodrigues D; Asensi KD; Vairo L; Azevedo-Pereira RL; Silva R; Rondinelli E; Goldenberg RC; Campos de Carvalho AC; Urményi TP
    Cell Transplant; 2012; 21(10):2215-24. PubMed ID: 22776164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).
    Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G
    J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells from human placental chorion for perinatal tissue engineering applications.
    Jiang G; Di Bernardo J; DeLong CJ; Monteiro da Rocha A; O'Shea KS; Kunisaki SM
    Tissue Eng Part C Methods; 2014 Sep; 20(9):731-40. PubMed ID: 24447109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic mRNA Reprogramming of Human Fibroblast Cells.
    Liu J; Verma PJ
    Methods Mol Biol; 2015; 1330():17-28. PubMed ID: 26621585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
    Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
    Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of endometrial adult stromal cells in the presence of a ROCK inhibitor, thiazovivin, could obtain more efficient iPSCs.
    Mohseni R; Shoae-Hassani A; Verdi J
    Cell Biol Int; 2015 May; 39(5):515-8. PubMed ID: 25490878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
    Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
    Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
    Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
    Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts.
    Questa M; Romorini L; Blüguermann C; Solari CM; Neiman G; Luzzani C; Scassa MÉ; Sevlever GE; Guberman AS; Miriuka SG
    Stem Cell Res; 2016 Mar; 16(2):300-3. PubMed ID: 27345989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
    Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
    Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.